MedPath

se of oxytocin at different rates for contraction of uterus during caesarean delivery in patients in labour

Phase 4
Completed
Conditions
Health Condition 1: null- Full term pregnant patients in labour undergoing caesarean section
Registration Number
CTRI/2017/11/010496
Lead Sponsor
niversity College of Medical Sciences and GTB Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
105
Inclusion Criteria

Healthy females with 37 weeks or more gestation,

Uncomplicated, singleton pregnancy,

Labouring patients who have received oxytocin for induction or augmentation of labour

Exclusion Criteria

Known drug allergy to oxytocin,

Maternal complications e.g. pre-eclampsia, diabetes mellitus, cardiovascular disease, cerebrovascular disease, bronchial asthma,

Known risk factors for postpartum haemorrhage e.g. Multiple gestation, abnormal placentation, uterine fibroid, macrosomia, hydramnios, history of postpartum haemorrhage or uterine atony

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Estimated blood loss during intraoperative periodTimepoint: Estimated blood loss during intraoperative period
Secondary Outcome Measures
NameTimeMethod
Adequacy of uterine tone, <br/ ><br>Need for additional uterotonics, <br/ ><br>Haemoglobin level at 4 and 24 hours, <br/ ><br>Any oxytocin related side-effectsTimepoint: During surgery and till 24 hours after surgery
© Copyright 2025. All Rights Reserved by MedPath